Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study

Elizabeth Stenger, Tami D. John, Deepak Chellapandian, Rikin Shah, Scott Gillespie, Yijin Xiang, Katie Liu, Monica Bhatia, Gregory M.T. Guilcher, Jennifer Jaroscak, Kimberly A. Kasow, Jennifer Krajewski, Alexander I. Ngwube, Hemalatha G. Rangarajan, John T. Horan, Lakshmanan Krishnamurti, Shalini Shenoy, Allistair Abraham

Blood (2023) 142 (Supplement 1): 4955.

https://doi.org/10.1182/blood-2023-188514

Published: 2023

Journal Articles

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Blood (2023) 142 (Supplement 1): 1052.

https://doi.org/10.1182/blood-2023-190139

Published: 2023

Journal Articles

Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study

Blood (2023) 142 (Supplement 1): 4904.

https://doi.org/10.1182/blood-2023-182532

Published: 2023

Journal Articles

DNA Methylation Changes in Nucleated Red Blood Cells from Patients with Sickle Cell Disease: A Potential Marker of Engraftment after Stem Cell Transplantation

Jasmine Lewis, Nicolas Prud'homme, Ellen Kennedy, Fatima Iqbal, Amit Kalra, Pauline de Jesus, Gurpreet Singh, Monica Bhatia, Faisal Khan, Steven C. Greenway, Gregory M.T. Guilcher

Blood (2023) 142 (Supplement 1): 3866.

https://doi.org/10.1182/blood-2023-179840

Published: 2023

Journal Articles

Two Hit Theory for the Pathogenesis of Type 3 Congenital Amegakaryocytic Thrombocytopenia

Urvi Kapoor, Shipra Kaicker, Jenny Shek, Robyn Gartrell, Monica Bhatia

Blood (2023) 142 (Supplement 1): 5454.

https://doi.org/10.1182/blood-2023-190490

Published: 2023

Journal Articles

Gonadal Hormone Production after Hematopoietic Cell Transplant (HCT) in Patients with Sickle Cell Disease (SCD): A Stellar Study

Sobenna A George, Anirudh Veludhandi, Yijin Xiang, Elizabeth Stenger, Staci D. Arnold, Akanksha Mehta, David A Schirmer, Jessica B Spencer, Gregory M Guilcher, Monica Bhatia, Allistair Abraham, Veronica Gomez-Lobo, Lakshmanan Krishnamurti, Lillian R Meacham

Blood (2022) 140 (Supplement 1): 1391–1392.

https://doi.org/10.1182/blood-2022-168060

Published: 2022

Journal Articles

Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Severe Sickle Cell Disease

Haydar Frangoul, Franco Locatelli, Monica Bhatia, Markus Y. Mapara, Lyndsay Molinari, Akshay Sharma, Stephan Lobitz, Mariane de Montalembert, Damiano Rondelli, Martin Steinberg, Mark C. Walters, Suzan Imren, Lanju Zhang, Anjali Sharma, Yang Song, Christopher Simard, William Hobbs, Stephen Grupp

Blood (2022) 140 (Supplement 1): 29–31.

https://doi.org/10.1182/blood-2022-162353

Published: 2022

Journal Articles

Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease

Blood (2022) 139 (2): 287–299.

https://doi.org/10.1182/blood.2021013244

Published: 2022

Includes: Supplemental data

Journal Articles

Long-Term Quality of Life after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from the Sickle Cell Transplant Evaluation of Long Term and Late Effects Registry (STELLAR)

Staci D. Arnold, Nitya Bakshi, Zhao Chang, Diana Ross, Allistair Abraham, Monica Bhatia, Gregory M.T. Guilcher, Ann Haight, Matthew Hsieh, Kimberly A. Kasow, Peter A. Lane, Lillian Meacham, Festus Olusola Olowoselu, Lakshmanan Krishnamurti

Blood (2021) 138 (Supplement 1): 425.

https://doi.org/10.1182/blood-2021-154280

Published: 2021

Journal Articles

Nonmyeloablative HLA-Identical Sibling Donor Transplantation for Children and Young Adults with Sickle Cell Disease: Interim Results of the SUN Multicenter Phase II Trial

Robert Sheppard Nickel, KY Chiang, Steven J. Hardy, Hemalatha G Rangarajan, Sonali Chaudhury, Michael Kent, Monica Bhatia, Jeremy Zack, Vivitha Mani, Gregory M.T. Guilcher, Allistair Abraham

Blood (2021) 138 (Supplement 1): 1799.

https://doi.org/10.1182/blood-2021-144454

Published: 2021

Journal Articles

Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)

Anirudh Veludhandi, Tami D John, Nitya Bakshi, Staci D. Arnold, Monica Bhatia, Peter A. Lane, Lillian Meacham, Kirshma Khemani, Sonali Chaudhury, Festus Olusola Olowoselu, Kimberly A. Kasow, Matthew Hsieh, Allistair Abraham, Gregory M.T. Guilcher, Lakshmanan Krishnamurti

Blood (2021) 138 (Supplement 1): 3030.

https://doi.org/10.1182/blood-2021-152383

Published: 2021

Journal Articles

Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated Following Allogeneic Transplantation in Patients with Sickle Cell Disease

Niketa C. Shah, MD, Sweta Bhoopatiraju, Allistair Abraham, MD, Eric Jon Anderson, MD, Martin Andreansky, MD, Monica Bhatia, MD, Sonali Chaudhury, MD, Geoff D.E. Cuvelier, MD, Kamar Godder, MD MPH, Michael Grimley, MD, Gregory Hale, MD, Naynesh Kamani, David Jacobsohn, MD, Alexander I. Ngwube, MD, Jodi L. Skiles, MD, Lolie C. Yu, MD, Shalini Shenoy, MD

Blood (2020) 136 (Supplement 1): 33.

https://doi.org/10.1182/blood-2020-142696

Published: 2020

Journal Articles

Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-139031

Published: 2020

Journal Articles

Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies

Blood (2020) 135 (15): 1287–1298.

https://doi.org/10.1182/blood.2019003186

Published: 2020

Includes: Supplemental data

Journal Articles

Excellent Survival and Immune Reconstitution Following Matched/Mismatched Unrelated and Mismatched Related Transplantation in Adult Patients with Sickle Cell Disease: Updated Results from a Single Center Experience

Amer Assal, MD, Diane George, MD, Monica Bhatia, MD, Divaya Bhutani, MD, Christian Gordillo, BS, Suzanne Lentzsch, MD PhD, Ran Reshef, MDMSc, Markus Y Mapara, MD PhD

Blood (2019) 134 (Supplement_1): 2043.

https://doi.org/10.1182/blood-2019-132113

Published: 2019

Journal Articles

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria

Blood (2019) 134 (3): 304–316.

https://doi.org/10.1182/blood.2019000216

Published: 2019

Includes: Supplemental data

Journal Articles

Curative Allogeneic Stem Cell Transplantation Is Safe and Feasible in Adult Patients with Sickle Cell Disease Despite Lack of Matched Sibling Donor and Presence of Sickle Cell-Related Co-Morbidities

Amer Assal, MD, Diane George, MD, Monica Bhatia, MD, Christian Gordillo, BS, Nicole Howard, BS, Ran Reshef, MD MSc, Markus Y Mapara, MD PhD

Blood (2018) 132 (Supplement 1): 5713.

https://doi.org/10.1182/blood-2018-99-116538

Published: 2018

Journal Articles

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

Blood (2017) 129 (11): 1548–1556.

https://doi.org/10.1182/blood-2016-10-745711

Published: 2017

Journal Articles

Case Series of Pediatric Sickle Retinopathy By Sensitive Clinical Imaging Technologies Suggests Frequent Early Pathology

Pahl A. Daniel, BS, Nancy S. Green, MD, Monica Bhatia, MD, Maureen Licursi, Courtney Briamonte, NP, Elana Smilow, NP, Jonathan S. Chang, MD, Margaret T. Lee, MD MS, Royce W.S. Chen, MD

Blood (2016) 128 (22): 3672.

https://doi.org/10.1182/blood.V128.22.3672.3672

Published: 2016

Journal Articles

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease

Blood (2016) 128 (21): 2561–2567.

https://doi.org/10.1182/blood-2016-05-715870

Published: 2016

Includes: Supplemental data

NARROW

Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study

DNA Methylation Changes in Nucleated Red Blood Cells from Patients with Sickle Cell Disease: A Potential Marker of Engraftment after Stem Cell Transplantation

Two Hit Theory for the Pathogenesis of Type 3 Congenital Amegakaryocytic Thrombocytopenia

Gonadal Hormone Production after Hematopoietic Cell Transplant (HCT) in Patients with Sickle Cell Disease (SCD): A Stellar Study

Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Severe Sickle Cell Disease

Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease

Long-Term Quality of Life after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from the Sickle Cell Transplant Evaluation of Long Term and Late Effects Registry (STELLAR)

Nonmyeloablative HLA-Identical Sibling Donor Transplantation for Children and Young Adults with Sickle Cell Disease: Interim Results of the SUN Multicenter Phase II Trial

Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)

Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated Following Allogeneic Transplantation in Patients with Sickle Cell Disease

Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study

Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies

Excellent Survival and Immune Reconstitution Following Matched/Mismatched Unrelated and Mismatched Related Transplantation in Adult Patients with Sickle Cell Disease: Updated Results from a Single Center Experience

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria

Curative Allogeneic Stem Cell Transplantation Is Safe and Feasible in Adult Patients with Sickle Cell Disease Despite Lack of Matched Sibling Donor and Presence of Sickle Cell-Related Co-Morbidities

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

Case Series of Pediatric Sickle Retinopathy By Sensitive Clinical Imaging Technologies Suggests Frequent Early Pathology

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only